An eating disorder is a complex mental health condition often requiring psychiatric and medical support. There is a common misconception that certain eating habits, like overeating, are healthy lifestyle choices. However, eating disorders develop as individuals fixate on food, body weight, and size, leading to severe health complications such as diabetes, cardiovascular diseases, anxiety, depression, and more. It is crucial to understand that eating disorders are serious illnesses that require proper diagnosis, treatment, and support to address the condition's physical and psychological aspects.
According to Data Bridge Market Research, the Eating Disorder Market is expected to grow with a CAGR of 5.8% in the forecast period of 2022 to 2029.
“Rise in the prevalence of binge eating disorder boosts the market’s growth”
The rise in the prevalence of binge eating disorders is driving the growth of the eating disorder market. Binge eating disorder is a severe mental health condition characterized by recurrent episodes of consuming large quantities of food within a short period and a feeling of loss of control. The increasing recognition and diagnosis of this disorder, along with growing awareness and improved access to treatment options, have contributed to the expansion of the eating disorder market as more individuals seek help and support for their condition.
What restraints the growth of the eating disorder market?
“Potential side effects of available treatments restraints the market’s growth”
Concerns regarding the potential side effects of available treatments hinder the growth of the eating disorders market. While treatment options such as psychotherapy and medication are effective in managing eating disorders, there are potential risks and adverse effects associated with these interventions. Concerns about the safety and tolerability of treatments have led to hesitation among patients and healthcare providers, resulting in limited adoption and slower market growth. Addressing these concerns through research, innovation, and improved safety profiles of treatment options is crucial for fostering market expansion in the eating disorders field.
Segmentation: Eating Disorder Market
The eating disorder market is segmented on the basis of type, treatment, patients, route of administration, end-users and distribution channel.
- On the basis of type, the eating disorder market has been segmented into anorexia nervosa, bulimia nervosa, binge eating disorder, pica, rumination disorder, avoidant/restrictive food intake disorder, purging disorder, night eating syndrome and others.
- On the basis of treatment, the eating disorder market has been segmented into medications, therapies and others.
- On the basis of patients, the eating disorder market has been segmented into inpatients and outpatients.
- On the basis of route of administration, the eating disorder market has been segmented into oral, parenteral, and others.
- On the basis of end-users, the eating disorder market has been segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the eating disorder market has been segmented into hospital pharmacy, retail pharmacy and others.
Regional Insights: North America dominates the eating disorder market
North America dominates the eating disorder market because of the high prevalence of obesity among the population in the region is a key factor driving the growth of the eating disorders market. Obesity is closely linked to eating disorders, and the increasing rates of obesity contribute to a higher demand for treatments and interventions targeting these conditions.
Asia-Pacific is expected to witness high growth during the forecast period of 2022 to 2029 owing to the attributed to the large population within the region. With a larger population base, there is an increased likelihood of individuals experiencing eating disorders, leading to a higher demand for diagnosis, treatment, and support services, which in turn drives the growth of the market.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-eating-disorders-eds-market
The Prominent Key Players Operating in the Eating Disorder Market Include:
- Bausch & Lomb Incorporated (U.S.)
- Apotex Inc. (Canada)
- Somerset Therapeutics, LLC (U.S.)
- Mylan N.V. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Pfizer Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Amneal Pharmaceutical LLC. (U.S.)
- Eli Lilly and Company (U.S.)
- AbbVie Inc. (U.S.)
- GlaxoSmithKline Plc (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of eating disorder market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Eating Disorder Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
